Cargando…

Comorbidity in patients with branch retinal vein occlusion: case-control study

Objectives To evaluate comorbidity before and after the diagnosis of branch retinal vein occlusion to determine whether it is a consequence of arterial thickening and therefore could serve as a diagnostic marker for other comorbidities and to evaluate the risk factors for the development of such occ...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertelsen, Mette, Linneberg, Allan, Rosenberg, Thomas, Christoffersen, Nynne, Vorum, Henrik, Gade, Else, Larsen, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510781/
https://www.ncbi.nlm.nih.gov/pubmed/23204001
http://dx.doi.org/10.1136/bmj.e7885
_version_ 1782251499689082880
author Bertelsen, Mette
Linneberg, Allan
Rosenberg, Thomas
Christoffersen, Nynne
Vorum, Henrik
Gade, Else
Larsen, Michael
author_facet Bertelsen, Mette
Linneberg, Allan
Rosenberg, Thomas
Christoffersen, Nynne
Vorum, Henrik
Gade, Else
Larsen, Michael
author_sort Bertelsen, Mette
collection PubMed
description Objectives To evaluate comorbidity before and after the diagnosis of branch retinal vein occlusion to determine whether it is a consequence of arterial thickening and therefore could serve as a diagnostic marker for other comorbidities and to evaluate the risk factors for the development of such occlusion. Design Case-control study with prospective follow-up data from Danish national registries. Setting Four secondary referral centres covering about 80% of the Danish population (4.4 million). Participants 1168 patients with photographically verified branch retinal vein occlusion and 116 800 controls alive and aged ≥40 when the occlusion was diagnosed in the corresponding case. Main outcome measures The risk of comorbidity 10 years and 1 year before the diagnosis of branch retinal vein occlusion and the incident comorbidity in a mean period of seven years after the diagnosis, with odds ratios and incidence rate ratios adjusted for age, sex, and year of diagnosis. Results Risk factors present 10 years and 1 year before the diagnosis of branch retinal vein occlusion included peripheral artery disease (odds ratio 1.83, 95% confidence interval 1.14 to 2.95), diabetes (1.74, 1.40 to 2.17) and arterial hypertension (2.16, 1.86 to 2.51). After the diagnosis, patients had an increased risk of developing arterial hypertension (incidence rate ratio 1.37, 95% confidence interval 1.15 to 1.57), diabetes (1.51, 1.17 to 2.04), congestive heart failure (1.41, 1.12 to 1.68), and cerebrovascular disease (1.49, 1.27 to 1.76). Conclusion Diabetes, hypertension, and peripheral artery disease are associated with an increased risk of developing branch retinal vein occlusion up to a decade later. Branch retinal vein occlusion was associated with an increased risk of subsequently developing hypertension, diabetes, congestive heart failure, and cerebrovascular disease, emphasising the importance of preventive initiatives. These results fit the assumption that branch retinal vein occlusion is a consequence of arterial thickening and that the arteriovenous crossing signs that precede it are hallmarks of arterial disease.
format Online
Article
Text
id pubmed-3510781
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-35107812012-12-03 Comorbidity in patients with branch retinal vein occlusion: case-control study Bertelsen, Mette Linneberg, Allan Rosenberg, Thomas Christoffersen, Nynne Vorum, Henrik Gade, Else Larsen, Michael BMJ Research Objectives To evaluate comorbidity before and after the diagnosis of branch retinal vein occlusion to determine whether it is a consequence of arterial thickening and therefore could serve as a diagnostic marker for other comorbidities and to evaluate the risk factors for the development of such occlusion. Design Case-control study with prospective follow-up data from Danish national registries. Setting Four secondary referral centres covering about 80% of the Danish population (4.4 million). Participants 1168 patients with photographically verified branch retinal vein occlusion and 116 800 controls alive and aged ≥40 when the occlusion was diagnosed in the corresponding case. Main outcome measures The risk of comorbidity 10 years and 1 year before the diagnosis of branch retinal vein occlusion and the incident comorbidity in a mean period of seven years after the diagnosis, with odds ratios and incidence rate ratios adjusted for age, sex, and year of diagnosis. Results Risk factors present 10 years and 1 year before the diagnosis of branch retinal vein occlusion included peripheral artery disease (odds ratio 1.83, 95% confidence interval 1.14 to 2.95), diabetes (1.74, 1.40 to 2.17) and arterial hypertension (2.16, 1.86 to 2.51). After the diagnosis, patients had an increased risk of developing arterial hypertension (incidence rate ratio 1.37, 95% confidence interval 1.15 to 1.57), diabetes (1.51, 1.17 to 2.04), congestive heart failure (1.41, 1.12 to 1.68), and cerebrovascular disease (1.49, 1.27 to 1.76). Conclusion Diabetes, hypertension, and peripheral artery disease are associated with an increased risk of developing branch retinal vein occlusion up to a decade later. Branch retinal vein occlusion was associated with an increased risk of subsequently developing hypertension, diabetes, congestive heart failure, and cerebrovascular disease, emphasising the importance of preventive initiatives. These results fit the assumption that branch retinal vein occlusion is a consequence of arterial thickening and that the arteriovenous crossing signs that precede it are hallmarks of arterial disease. BMJ Publishing Group Ltd. 2012-11-30 /pmc/articles/PMC3510781/ /pubmed/23204001 http://dx.doi.org/10.1136/bmj.e7885 Text en © Bertelsen et al 2012 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Research
Bertelsen, Mette
Linneberg, Allan
Rosenberg, Thomas
Christoffersen, Nynne
Vorum, Henrik
Gade, Else
Larsen, Michael
Comorbidity in patients with branch retinal vein occlusion: case-control study
title Comorbidity in patients with branch retinal vein occlusion: case-control study
title_full Comorbidity in patients with branch retinal vein occlusion: case-control study
title_fullStr Comorbidity in patients with branch retinal vein occlusion: case-control study
title_full_unstemmed Comorbidity in patients with branch retinal vein occlusion: case-control study
title_short Comorbidity in patients with branch retinal vein occlusion: case-control study
title_sort comorbidity in patients with branch retinal vein occlusion: case-control study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510781/
https://www.ncbi.nlm.nih.gov/pubmed/23204001
http://dx.doi.org/10.1136/bmj.e7885
work_keys_str_mv AT bertelsenmette comorbidityinpatientswithbranchretinalveinocclusioncasecontrolstudy
AT linnebergallan comorbidityinpatientswithbranchretinalveinocclusioncasecontrolstudy
AT rosenbergthomas comorbidityinpatientswithbranchretinalveinocclusioncasecontrolstudy
AT christoffersennynne comorbidityinpatientswithbranchretinalveinocclusioncasecontrolstudy
AT vorumhenrik comorbidityinpatientswithbranchretinalveinocclusioncasecontrolstudy
AT gadeelse comorbidityinpatientswithbranchretinalveinocclusioncasecontrolstudy
AT larsenmichael comorbidityinpatientswithbranchretinalveinocclusioncasecontrolstudy